Jobs

T32 Postdoctoral Trainee

Employer

University of Kentucky

Location

Lexington, Kentucky

Principal Investigator

Elizabeth Head/Linda Van Eldik

Contact

Applicants should send an email that includes a cover letter with a brief statement of research experience and career goals, a curriculum vitae, and names and contact information for three references to Elizabeth Head at Elizabeth.head@uky.edu.

Description

Training in Translational Research in Alzheimer’s and Related Dementias (TRIAD) T32 Program

A two-year postdoctoral trainee position is available at the University of Kentucky. The position is in the Sanders-Brown Center on Aging, an established research center in aging and dementia where independent basic and clinical scientists work in a collaborative environment. The Center on Aging also includes the NIH-funded Alzheimer’s Disease Center that provides unique and outstanding resources to support innovative research (e.g., longitudinally followed and well-characterized clinical cohorts, neuroimaging, biomarkers, autopsy specimens).

The successful candidate will benefit from an experienced mentor, a stimulating and collaborative research environment, and an organized training plan. There are ample opportunities for scientific growth, career enhancement, and development into an independent investigator in academia.

The program will provide training in: (1) Alzheimer disease and related dementias—bench to bedside; (2) bioethics; (3) career development; (4) grant writing; (5) learning how to mentor and; (6) individual developmental plans. Postdoctoral trainees are invited to participate in the annual postdoctoral poster session and Markesbery symposium. In addition, a short research externship is supported under this funding and is encouraged, as is travel to scientific conferences.

Requirements

Applicants should be highly motivated, creative, and collaborative, and interested in working with a mentor and participating in training activities.

A Ph.D. or M.D./Ph.D. in an area relevant to Alzheimer’s disease and related dementias and/or neuroscience is required. U.S. citizenship or permanent residence is also required. Available to start September 1, 2018.